CD14 and psoriasis: Treatment with Etanercept for 24 weeks did not alter VDR expression on CD3+ and CD14+ cells in this cohort of patients with psoriasis with sufficient serum vitamin D levels at the treatment’s start, implying that VDR expression might not be related to disease severity or the grade of inflammation.